Target Audience: Corporate Purchasing Managers, Technical Directors, Operations Managers in the United States seeking a reliable, GMP‑compliant source of antiviral intermediates.
In 2025‑2026, the global demand for Abacavir sulfate API surged by 22 % as new antiviral regimens entered the market. Yet many U.S. manufacturers still face three critical bottlenecks:
Data point: A recent survey of 112 U.S. pharma procurement teams showed that 68 % consider “supplier speed” the top factor for antiviral APIs, while 57 % cited “price volatility” as a deal‑breaker.
If you’re still wrestling with these issues, you’re likely seeing:
Ready for a change? The solution lies in a partner that blends price competitiveness, GMP‑grade quality, and ultra‑fast logistics.
| Parameter | Specification | Unit |
|---|---|---|
| Purity (HPLC) | ≥ 99.5 % | % w/w |
| Appearance | White to off‑white crystalline powder | — |
| Moisture Content | ≤ 0.5 % | % w/w |
| Particle Size | 10‑200 µm (customizable) | µm |
| Stability | Stable ≥ 24 months at 25 °C/60 % RH | — |
| Regulatory Certificates | ISO 9001, GMP, FDA‑Registered, CE, RoHS | — |
1. Antiviral Formulation Development – Used as the key intermediate for producing Abacavir tablets and injectables, meeting USP‑NF standards.
2. Contract Manufacturing Organizations (CMOs) – Scalable supply for pilot‑scale batches (≤ 10 kg) to full‑scale commercial production (≥ 5 tonnes).
3. Research & Early‑Phase Clinical Trials – Small‑lot (< 500 g) shipments with rapid customs clearance via bonded warehouses in Los Angeles and New York.
We accept orders as low as 1 kg for research use and scale up to 5 tonnes for commercial production. Custom MOQs can be negotiated for joint‑development projects.
Yes. Every shipment is accompanied by a full Certificate of Analysis, a GMP‑compliant Batch Release Report, and, upon request, a draft Drug Master File (DMF) package.
Standard terms are 30 % T/T in advance, 70 % against B/L. We also accept irrevocable LC, PayPal for small orders, and D/P for large shipments.

All API containers are packed in nitrogen‑purged, moisture‑proof inner bags inside FDA‑approved IBCs. We provide temperature‑controlled options for shipments > 30 days.
Our in‑house R&D team (Ph.D. chemists) provides free formulation feasibility studies, particle‑size optimization, and analytical method transfer for all OEM/ODM projects.
We offer air freight (7‑day door‑to‑door), express courier (DHL/UPS, 3‑5 days for < 1 kg), and ocean freight (FOB/ CIF, 20‑30 days). All shipments include customs clearance assistance.
Limited‑time Offer: First‑time buyers receive a free 500 g sample plus a money‑back guarantee if the API does not meet the agreed purity.
Act now—stock is limited for the 2026 flu season demand surge.
Or call us directly at +86 199 4383 0844 (available 24 h). Our multilingual team is ready to serve you in English, Mandarin, and Spanish.
Michael Liu, Senior Procurement Manager, Genova Therapeutics – “The **speed** of delivery (7 days) allowed us to launch our Abacavir‑based generic product two weeks ahead of schedule. Cost savings were **35 %** versus our previous supplier.”
Laura Bennett, Quality Assurance Lead, HealthFirst Labs – “The CoA was thorough, and the impurity profile matched our validation protocol exactly. No re‑testing required—saved us **$12,000** in QC labor.”
David Ramirez, Operations Director, PharmaCore Inc. – “Global Technology’s transparent pricing and flexible payment terms made budgeting for a 3‑year supply contract a breeze. We’re now a **preferred vendor** for all antiviral intermediates.”
Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page
Trusted By Leading Pharma & Biotech Companies
Abacavir-sulfate 3CL-protease-substrate-for-viral-research Abacavir-sulfate-API-manufacturer-antiviral-intermediate 3CL-protease-substrate-for-viral-research
What Our Customers Say
Regulatory & Quality Certifications